TY - JOUR
T1 - Natural history of thyroid function in ageing
T2 - an individual participant data analysis of 137 488 participants from 31 prospective cohort studies
AU - Thyroid Studies Collaboration
AU - Xu, Yanning
AU - Hysaj, Ola
AU - Qi, Xiaoyi
AU - Feller, Martin
AU - Pingitore, Alessandro
AU - Brown, Suzanne J.
AU - Ittermann, Till
AU - Iacoviello, Massimo
AU - Trompet, Stella
AU - Han, Ji Won
AU - Schmidt, Börge
AU - Sgarbi, José A.
AU - Valdés, Sergio
AU - Muendlein, Axel
AU - Riis, Johannes
AU - Andersen, Stig
AU - Drexel, Heinz
AU - Teumer, Alexander
AU - Dörr, Marcus
AU - Vanderpump, Mark P.J.
AU - Wareham, Nick
AU - Vaes, Bert
AU - Visser, W. Edward
AU - Jukema, J. Wouter
AU - Imaizumi, Misa
AU - Dullaart, Robin P.F.
AU - Medici, Marco
AU - Fink, Howard A.
AU - Ceresini, Graziano
AU - Ferrucci, Luigi
AU - Ikram, M. Arfan
AU - Hankey, Graeme J.
AU - Iervasi, Giorgio
AU - Eastell, Richard
AU - Bauer, Douglas C.
AU - Williams, Graham R.
AU - Boelaert, Kristien
AU - Psaty, Bruce M.
AU - Führer-Sakel, Dagmar
AU - Bakker, Stephan J.L.
AU - Kiemeney, Lambertus A.L.M.
AU - Riksen, Niels P.
AU - Kim, Ki Woong
AU - Azizi, Fereidoun
AU - Völzke, Henry
AU - Yeap, Bu B.
AU - Razvi, Salman
AU - Gussekloo, Jacobijn
AU - Walsh, John P.
AU - Fink, Howard A.
N1 - Publisher Copyright:
© 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
PY - 2026/6
Y1 - 2026/6
N2 - Background: Evidence regarding thyroid function changes with ageing remains inconsistent and the implications of potential changes are unclear. We aimed to investigate ageing-related thyroid function changes and their associations with mortality. Methods: In this individual participant data (IPD) analysis, prospective population-based cohorts were eligible for inclusion when data on thyroid function measurements and mortality were available in individuals aged 18 years and older. Eligible datasets were identified through a systematic search of PubMed. We excluded cohorts of participants with only thyroid disease or thyroid-altering medications, or pregnant individuals. We requested data from all eligible cohorts that agreed to participate in the study. Linear mixed models were used to investigate associations between age and thyroid function, stratified for sex and regional iodine status. Annual changes in thyroid-stimulating hormone (TSH) and free thyroxine (FT4) were estimated per individual and categorised into quintiles, with the highest and lowest quintiles defined as increasing and decreasing, respectively, and the rest as stable. Patterns of thyroid function change were identified based on combined TSH and FT4 evolution. We used cohort-stratified Cox models to assess associations between changing patterns and all-cause mortality. This study is registered with PROSPERO, CRD42023408086. Findings: In this IPD analysis, we analysed data collected between Jan 1, 2011, and Oct 13, 2022, from 31 cohorts across Europe (n=19), the USA (n=5), Asia (n=3), Brazil (n=2), and Australia (n=2; 137 488 participants; 68 322 [49·7%] were female and 69 166 [50·3%] were male; median age 60 years [range 18–106]). Cross-sectionally, older age was associated with higher TSH in iodine-sufficient regions and with lower TSH in iodine-insufficient regions. Longitudinal analyses showed that TSH increased with increasing age regardless of iodine status. The overall increase in TSH from age 18 years to 100 years was 0·61 mIU/L (0·52 SD) for female participants and 0·99 mIU/L (0·76) for male participants from iodine-sufficient regions. Greater variability in population distribution and longitudinal TSH changes was observed in adults aged 65 years or older. Higher FT4 with older age was suggested cross-sectionally, but longitudinally FT4 increased in iodine-sufficient regions and decreased in iodine-insufficient regions. Compared with stable thyroid function, all changing patterns were associated with increased all-cause mortality: hazard ratios of 1·80 (95% CI 1·57–2·06) for increasing TSH with stable or decreasing FT4; 2·45 (2·01–2·97) for increasing TSH and increasing FT4; 2·45 (1·99–3·01) for decreasing TSH with decreasing FT4; and 1·94 (1·68–2·24) for decreasing TSH with stable or increasing FT4. Interpretation: Ageing-related changes in thyroid function varied by sex and iodine status. Most individuals had stable thyroid function during ageing with a slight increase in TSH, although older adults displayed greater variability. Patterns of changing thyroid function were associated with an increased all-cause mortality risk, warranting further exploration of the underlying mechanisms and clinical management. Funding: None.
AB - Background: Evidence regarding thyroid function changes with ageing remains inconsistent and the implications of potential changes are unclear. We aimed to investigate ageing-related thyroid function changes and their associations with mortality. Methods: In this individual participant data (IPD) analysis, prospective population-based cohorts were eligible for inclusion when data on thyroid function measurements and mortality were available in individuals aged 18 years and older. Eligible datasets were identified through a systematic search of PubMed. We excluded cohorts of participants with only thyroid disease or thyroid-altering medications, or pregnant individuals. We requested data from all eligible cohorts that agreed to participate in the study. Linear mixed models were used to investigate associations between age and thyroid function, stratified for sex and regional iodine status. Annual changes in thyroid-stimulating hormone (TSH) and free thyroxine (FT4) were estimated per individual and categorised into quintiles, with the highest and lowest quintiles defined as increasing and decreasing, respectively, and the rest as stable. Patterns of thyroid function change were identified based on combined TSH and FT4 evolution. We used cohort-stratified Cox models to assess associations between changing patterns and all-cause mortality. This study is registered with PROSPERO, CRD42023408086. Findings: In this IPD analysis, we analysed data collected between Jan 1, 2011, and Oct 13, 2022, from 31 cohorts across Europe (n=19), the USA (n=5), Asia (n=3), Brazil (n=2), and Australia (n=2; 137 488 participants; 68 322 [49·7%] were female and 69 166 [50·3%] were male; median age 60 years [range 18–106]). Cross-sectionally, older age was associated with higher TSH in iodine-sufficient regions and with lower TSH in iodine-insufficient regions. Longitudinal analyses showed that TSH increased with increasing age regardless of iodine status. The overall increase in TSH from age 18 years to 100 years was 0·61 mIU/L (0·52 SD) for female participants and 0·99 mIU/L (0·76) for male participants from iodine-sufficient regions. Greater variability in population distribution and longitudinal TSH changes was observed in adults aged 65 years or older. Higher FT4 with older age was suggested cross-sectionally, but longitudinally FT4 increased in iodine-sufficient regions and decreased in iodine-insufficient regions. Compared with stable thyroid function, all changing patterns were associated with increased all-cause mortality: hazard ratios of 1·80 (95% CI 1·57–2·06) for increasing TSH with stable or decreasing FT4; 2·45 (2·01–2·97) for increasing TSH and increasing FT4; 2·45 (1·99–3·01) for decreasing TSH with decreasing FT4; and 1·94 (1·68–2·24) for decreasing TSH with stable or increasing FT4. Interpretation: Ageing-related changes in thyroid function varied by sex and iodine status. Most individuals had stable thyroid function during ageing with a slight increase in TSH, although older adults displayed greater variability. Patterns of changing thyroid function were associated with an increased all-cause mortality risk, warranting further exploration of the underlying mechanisms and clinical management. Funding: None.
UR - https://www.scopus.com/pages/publications/105038809657
UR - https://www.scopus.com/pages/publications/105038809657#tab=citedBy
U2 - 10.1016/s2213-8587(26)00009-4
DO - 10.1016/s2213-8587(26)00009-4
M3 - Article
C2 - 42061390
AN - SCOPUS:105038809657
SN - 2213-8587
VL - 14
SP - 485
EP - 497
JO - The Lancet Diabetes and Endocrinology
JF - The Lancet Diabetes and Endocrinology
IS - 6
ER -